851199-04-7

Basic information

• Product Name: 1,3,2-Dioxaborolane, 2-[4-(1,1-dimethylpropyl)phenyl]-4,4,5,5-tetramethyl-
• CAS NO: 851199-04-7
• Molecular Formula: C17H27BO2
• Molecular Weight: 274.211
• Mol File: 851199-04-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1,3,2-Dioxaborolane, 2-[4-(1,1-dimethylpropyl)phenyl]-4,4,5,5-tetramethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,2-Dioxaborolane, 2-[4-(1,1-dimethylpropyl)phenyl]-4,4,5,5-tetramethyl-(851199-04-7)
• EPA Substance Registry System: 1,3,2-Dioxaborolane, 2-[4-(1,1-dimethylpropyl)phenyl]-4,4,5,5-tetramethyl-(851199-04-7)

Safety Data

• Hazardous Substances Data: 851199-04-7(Hazardous Substances Data)

Upstream product

• 851231-25-9 [4-(1,1-dimethylpropyl)phenyl]trifluoromethanesulfonate 
• 73183-34-3 bis(pinacol)diborane 
• 2049-95-8 tery-amylbenzene 
• 80-46-6 4-t-amylphenol 
• 25240-59-9 pinacolboronic acid 

Downstream Products

• 57263-21-5 4-tert-pentyl-bromobenzene 

Relevant articles and documents

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidases SpsB and/or LepB, an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS

The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression. The compounds act as potentiators on glutamate receptors, in particular AMPA and the GluR family.